HIGHLIGHTS
- What: The aim of this study was to evaluate patients over a 10-year period presenting with OPSCC to the institution and to assess if the number of cases of OPSCC was increasing. Patients were excluded for the following reasons: non-SCC histology, no documented P16 or HPV testing of tumour specimens, no treatment or follow-up data available and_(4) residual or recurrent oropharyngeal tumours. For this study, tumour staging was performed using the American Joint Committee on Cancer (AJCC) staging 7th edition. The majority of patients in this study had HPV-mediated OPSCC (59.5 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.